➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Mallinckrodt
Harvard Business School
Johnson and Johnson
Baxter

Last Updated: October 30, 2020

DrugPatentWatch Database Preview

Details for Patent: 7,458,372

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,458,372
Title:Inhalation therapy device
Abstract: The invention relates to an inhalation therapy device including a membrane aerosol generator. A detection device is provided for determining whether a liquid to be atomized is available. In the absence of liquid, the activation of the membrane aerosol generator is interrupted and/or a signal is output.
Inventor(s): Feiner; Franz (Munich, DE), Borgschulte; Markus (Munich, DE), Achtzehner; Wolfgang (Alling, DE), Kunschir; Eduard (Munich, DE), Lass; Joseph (Munich, DE)
Assignee: PARI Pharma GmbH (Starnberg, DE)
Application Number:10/533,430
Patent Claim Types:
see list of patent claims
Use; Device;

Drugs Protected by US Patent 7,458,372

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,458,372

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany102 50 625Oct 30, 2002
PCT Information
PCT FiledOctober 30, 2003PCT Application Number:PCT/EP03/12076
PCT Publication Date:May 13, 2004PCT Publication Number: WO2004/039442

International Family Members for US Patent 7,458,372

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 453424   Start Trial
Germany 10250625   Start Trial
Germany 50312299   Start Trial
European Patent Office 1558315   Start Trial
World Intellectual Property Organization (WIPO) 2004039442   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
McKinsey
Medtronic
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.